Horizon Pharma CEO Timothy Walbert's 2021 pay slips 1% to $21M
Horizon Pharma reports 2021 executive compensation
By ExecPay News
Published: March 17, 2022
Horizon Pharma reported fiscal year 2021 executive compensation information on March 17, 2022.
In 2021, six executives at Horizon Pharma received on average a compensation package of $10M, a 26% increase compared to previous year.
Average pay of disclosed executives at Horizon Pharma
Timothy P. Walbert, Chief Executive Officer, received $21M in total, which decreased by 1% compared to 2020. 74% of Walbert's compensation, or $16M, was in stock awards. Walbert also received $4.2M in non-equity incentive plan, $1.2M in salary, as well as $174K in other compensation.
For fiscal year 2021, the median employee pay was $298,200 at Horizon Pharma. Therefore, the ratio of Timothy P. Walbert's pay to the median employee pay was 72 to one.
Barry J. Moze, Chief Administrative Officer, received a compensation package of $10M, which increased by 106% compared to previous year. 81% of the compensation package, or $8.4M, was in stock awards.
Brian K. Beeler, General Counsel, earned $8M in 2021, a 113% increase compared to previous year.
Paul W. Hoelscher, Chief Financial Officer, received $7.3M in 2021, which increases by 24% compared to 2020.
Andy Pasternak, Executive Vice President, Chief Strategy Officer, earned $6.9M in 2021, a 19% increase compared to previous year.
Jeffrey W. Sherman, M.D., FACP, Chief Medical Officer, received $5.9M in 2021, which increases by 11% compared to 2020.
Related executives
Timothy Walbert
Horizon Pharma
Chief Executive Officer
Paul Hoelscher
Horizon Pharma
Chief Financial Officer
Andy Pasternak
Horizon Pharma
Executive Vice President, Chief Strategy Officer
Jeffrey FACP
Horizon Pharma
Chief Medical Officer
Barry Moze
Horizon Pharma
Chief Administrative Officer
Brian Beeler
Horizon Pharma
General Counsel
You may also like
Source: SEC filing on March 17, 2022.